asymptomatic hyperuricemia
Conditions
Interventions
experimental group:Chenpi enzyme
control group:Chenpi enzyme placebo
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years; 2. Male; 3. Those with blood uric acid values greater than or equal to 420 umol/L and without previous arthralgias; 4. Those who have not been treated with uric acid-lowering drugs; 5. Agree to participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with secondary hyperuricemia; 2. History of other comorbid diseases whose therapeutic use affects the determination of the efficacy of this study; 3. Patients with hemoglobin levels of less than 90 g/L, white blood cell counts less than 4.0 x 10^9 per liter, or platelet counts less than 100 x 10^9 per liter; 4. Patients with blood creatinine greater than 133 umol/L; glomerular filtration rate less than 90 mL/min; 5. Aspartate aminotransferase or alanine aminotransferase levels above the upper limit of the normal range; 6. A history of long-term glucocorticoid use; 7. Patients with active gastroduodenal ulcer or gastritis; 8. Patients with allergy to the test drug; 9. Patients who participated in other clinical trials within 4 weeks of screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood uric acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglycerides;Total cholesterol;Body weight; | — |
Countries
China
Contacts
Public ContactQingchun Huang
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed